Autism Spectrum / The Autism News FDA recently approved a trial - TopicsExpress



          

Autism Spectrum / The Autism News FDA recently approved a trial to enable researchers to determine whether stem cells obtained from umbilical cord blood at birth can cure autism. The trial’s goal is to evaluate whether stem cell’s therapy has any effect on language and behavioral difficulties experienced by autistic children. The rationale to pursue this trial was linked to the encouraging results of unpublished data examining the potential of stem cell therapy in children with cerebral palsy. While stem cell therapy has been previously used to treat immunologic disorders, cancer, and Parkinson’s disease, autism has been the area of recent scientific interests because of some encouraging results. Autism is a pervasive and highly variable neurodevelopmental disorder that affects the information processing in the brain by altering how nerve cells and neurons organize and connect. About nine in 1,000 children in the US are diagnosed with ASD (autism-spectrum disorders). Half of individuals with autism does not develop enough natural speech to meet their communication needs.
Posted on: Sun, 25 Aug 2013 00:21:33 +0000

Trending Topics



Recently Viewed Topics




© 2015